| Bioactivity | GPR183-IN-1 (compound 15) is a potent and orally activity GPR183 inhibitor. GPR183-IN-1 inhibits Ca2+ mobilization with an IC50 value of 39.97 nM. GPR183-IN-1 has the potential for the research of cancer, autoimmune diseases, pain, and osteoporosis[1]. |
| In Vivo | 药代动力学分析[1].Parameters |
| CAS | 2924063-70-5 |
| Formula | C16H19BrN2O2 |
| Molar Mass | 351.24 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. JianFei Xi, et al. Compounds and their use as GPR183 inhibitors. CN118201911A. |
GPR183-IN-1
CAS: 2924063-70-5 F: C16H19BrN2O2 W: 351.24
GPR183-IN-1 (compound 15) is a potent and orally activity GPR183 inhibitor. GPR183-IN-1 inhibits Ca2+ mobilization with
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.